Skip to main content
    I

    iRhythm Technologies Inc (IRTC)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $90.83
    -1.08 (-1.18%)

    Market Cap: $3.05B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    iRhythm Technologies Inc (IRTC) Financials: Revenue, Profit and Cash Flow

    Updated Nov 5, 2026. Financial statements from company filings, amounts in US dollars.

    iRhythm Technologies reported revenue of $747.14M for the fiscal year ended Dec 31, 2025, up 26.2% from the year before. That year, net income was -$44.55M with a net margin of -6.0%, operating cash flow was $80.86M and free cash flow was $34.52M. The quarter ended Sep 30, 2026 had revenue of $221.59M and net income of -$29.85M.

    Revenue and Margins

    The operating margin was -7.7% in the fiscal year ended Dec 2025, the highest of the 10 years shown. Over the 9 years to Dec 2025, revenue grew from $64.07M, a compound annual rate of 31.4%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$747.14M+26.2%70.6%-7.7%-6.0%
    Dec 2024$591.84M+20.1%68.9%-19.5%-19.1%
    Dec 2023$492.68M+19.9%67.3%-25.4%-25.0%
    Dec 2022$410.92M+27.3%68.5%-27.7%-28.3%
    Dec 2021$322.82M+21.7%66.2%-31.0%-31.4%
    Dec 2020$265.17M+23.6%73.5%-16.5%-16.5%
    Dec 2019$214.55M+45.7%75.5%-25.5%-25.4%
    Dec 2018$147.28M+48.6%73.7%-31.0%-34.2%
    Dec 2017$99.13M+54.7%71.5%-27.8%-30.0%
    Dec 2016$64.07MN/A67.4%-24.3%-32.6%
    Annual, fiscal years ended Dec 2016 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, the net loss narrowed from the year before. In the quarter ended Sep 2026, the net loss widened from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Revenue$747.14M$591.84M$492.68M$410.92M$322.82M$265.17M$214.55M$147.28M$99.13M$64.07M
    Cost of revenue$219.89M$184.31M$160.88M$129.29M$109.26M$70.28M$52.48M$38.80M$28.20M$20.88M
    Gross profit$527.25M$407.53M$331.81M$281.63M$213.57M$194.89M$162.07M$108.48M$70.93M$43.19M
    Research and development$87.65M$103.83M$60.24M$46.61M$38.67M$41.33M$37.30M$20.86M$13.27M$7.15M
    Operating income-$57.41M-$115.50M-$125.16M-$113.78M-$99.94M-$43.67M-$54.76M-$45.69M-$27.59M-$15.58M
    Net income-$44.55M-$113.29M-$123.41M-$116.16M-$101.36M-$43.83M-$54.57M-$50.38M-$29.74M-$20.90M
    EBITDA-$25.55M-$87.03M-$108.24M-$94.92M-$81.59M-$28.72M-$41.31M-$42.62M-$24.85MN/A
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$221.59M$224.17M$199.39M$208.89M$192.88M$186.69M$158.68M$164.32M$147.54M$148.05M$131.93M$132.51M
    Gross profit$164.49M$163.21M$141.35M$148.06M$137.12M$132.86M$109.22M$115.07M$101.48M$103.47M$87.52M$87.43M
    Operating income-$32.55M-$2.54M-$16.18M$2.29M-$8.43M-$18.71M-$32.56M-$4.08M-$50.30M-$22.98M-$38.14M-$39.18M
    Net income-$29.85M-$381.00K-$13.93M$5.58M-$5.21M-$14.22M-$30.70M-$1.33M-$46.18M-$20.11M-$45.67M-$38.70M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, total debt of $666.19M exceeded cash and equivalents by $430.18M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Total assets$1.02B$931.45M$433.14M$448.22M$462.97M$511.74M$306.21M$117.52M$133.38M$138.16M
    Current assets$702.76M$645.82M$230.81M$288.77M$305.52M$377.82M$172.79M$104.30M$119.76M$118.61M
    Cash and equivalents$236.01M$419.60M$36.17M$78.83M$127.56M$88.63M$20.46M$20.02M$8.67M$51.64M
    Total liabilities$867.30M$840.54M$223.05M$208.41M$183.45M$170.13M$170.80M$65.39M$70.15M$45.59M
    Short-term debt$16.69M$15.87M$15.16M$13.03M$11.67M$11.67M$1.94M$0$1.49M$32.23M
    Long-term debt$649.50M$646.44M$34.95M$34.94M$9.69M$21.34M$32.99M$34.90M$32.49M$32.23M
    Shareholder equity$152.75M$90.91M$210.10M$239.81M$279.51M$341.61M$135.41M$52.14M$79.34M$92.56M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$1.09B$1.09B$1.01B$1.02B$995.21M$964.03M$926.10M$931.45M$909.69M$919.18M$909.75M$433.14M
    Total liabilities$914.34M$907.44M$845.15M$867.30M$873.32M$860.37M$839.43M$840.54M$837.92M$820.00M$819.47M$223.05M
    Cash and equivalents$394.72M$246.68M$240.15M$236.01M$255.60M$309.11M$375.28M$419.60M$519.53M$550.55M$520.42M$36.17M
    Shareholder equity$177.11M$185.98M$161.21M$152.75M$121.89M$103.66M$86.67M$90.91M$71.77M$99.19M$90.29M$210.10M
    Last 12 quarters

    Cash Flow

    In the fiscal year ended Dec 2025, free cash flow was 42.7% of operating cash flow.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Operating cash flow$80.86M$3.39M-$50.10M-$23.01M-$37.75M-$13.76M-$21.86M-$29.09M-$14.91M-$16.65M
    Capital expenditures$46.34M$33.94M$40.42M$29.83M$28.07M$13.55M$20.46M$5.18M$3.56M$2.76M
    Free cash flow$34.52M-$30.55M-$90.53M-$52.84M-$65.82M-$27.31M-$42.32M-$34.27M-$18.47M-$19.41M
    Dividends paidN/AN/AN/AN/A$25.85M$10.01MN/AN/A$0$0
    Share repurchases$0$25.00M$0$0N/AN/AN/AN/AN/AN/A
    Investing cash flow-$277.06M-$122.98M-$1.21M-$52.43M$105.26M-$132.39M-$89.27M$34.14M-$34.68M-$68.17M
    Financing cash flow$12.61M$511.38M$8.82M$26.72M-$28.58M$214.32M$111.58M$6.30M$6.53M$111.25M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow$4.44M$51.08M-$26.17M$26.21M$34.88M$27.66M-$7.89M$19.23M$24.35M$11.84M-$52.03M-$15.97M
    Capital expenditures$15.98M$13.56M$6.91M$11.72M$14.83M$10.37M$9.42M$6.84M$8.83M$8.49M$9.78M$13.52M
    Free cash flow-$11.54M$37.52M-$33.08M$14.49M$20.05M$17.29M-$17.31M$12.39M$15.51M$3.35M-$61.80M-$29.49M
    Last 12 quarters

    Frequently Asked Questions About IRTC

    What is iRhythm Technologies' annual revenue?

    iRhythm Technologies reported revenue of $747.14M for the fiscal year ended Dec 31, 2025.

    How fast is iRhythm Technologies' revenue growing?

    Revenue was up 26.2% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 22.1%.

    Is iRhythm Technologies profitable?

    No. iRhythm Technologies reported net income of -$44.55M for the fiscal year ended Dec 31, 2025, with a net margin of -6.0%.

    How much free cash flow does IRTC generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of $80.86M minus capital expenditures of $46.34M produced free cash flow of $34.52M.

    How much debt does iRhythm Technologies have?

    The balance sheet dated Dec 31, 2025 reported long-term debt of $649.50M, short-term debt of $16.69M and cash and equivalents of $236.01M.